Viewing Study NCT01568892


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-02-02 @ 12:18 AM
Study NCT ID: NCT01568892
Status: COMPLETED
Last Update Posted: 2018-07-02
First Post: 2012-03-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Sponsor:
Organization: